[go: up one dir, main page]

HK1065534A - Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection - Google Patents

Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection Download PDF

Info

Publication number
HK1065534A
HK1065534A HK04108232.7A HK04108232A HK1065534A HK 1065534 A HK1065534 A HK 1065534A HK 04108232 A HK04108232 A HK 04108232A HK 1065534 A HK1065534 A HK 1065534A
Authority
HK
Hong Kong
Prior art keywords
hepatitis
treatment
virus infection
protease inhibitors
serine protease
Prior art date
Application number
HK04108232.7A
Other languages
Chinese (zh)
Inventor
Arasappan Ashok
Bennett Frank
L. Bogen Stephane
X. Chen Kevin
Jao Edwin
Liu Yi-Tsung
G. Lovey Raymond
S. Madison Vincent
G. Nair Latha
George Njoroge F.
K. Saksena Anil
Sannigrahi Mousumi
Venkatraman Srikanth
M. Girijavallabhan Viyyoor
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of HK1065534A publication Critical patent/HK1065534A/en

Links

HK04108232.7A 2002-01-23 2003-01-21 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection HK1065534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/350,931 2002-01-23

Publications (1)

Publication Number Publication Date
HK1065534A true HK1065534A (en) 2005-02-25

Family

ID=

Similar Documents

Publication Publication Date Title
IL162828A0 (en) Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
WO2007008657A3 (en) Hepatitis c virus inhibitors
IL162815A0 (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
AU2001282922A1 (en) Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
TW200508220A (en) Hepatitis C inhibitor compounds
WO2004032827A3 (en) Hepatitis c virus inhibitors
AU2003248535A1 (en) Heterocyclicsulfonamide hepatitis c virus inhibitors
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2003259155A1 (en) Pharmaceutical compositions comprising hepatitis c viral protease inhibitors
AU2002230763A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2001245356A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2001280640A1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
IL196815A0 (en) Hepatitis c virus inhibitors
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU2003249977A1 (en) Imidazole compounds for the treatment of hepatitis c virus infections
PL376409A1 (en) Composition for the treatment of infection by flaviviridae viruses
AU2003274537A1 (en) Pyrrolidine derivatives for use in treating heaptitis c virus infection
EP1583824A4 (en) Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
HK1065534A (en) Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
AU2003254129A1 (en) Method and composition for treating and preventing hepatitis b infection and symptoms thereof
AU2003266243A1 (en) 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors
AU2003299493A8 (en) Compositions and methods for the treatment of hepatitis c virus infection
AU2002350322A1 (en) Inhibitors of hepatitis c virus protease
HK1090930A (en) Depeptidized inhibitors of hepatitis c virus ns3 protease
HK1088339A (en) Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus